Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that the Company is having meeting with ‘Dhamma Capital’ on 26th March, 2025 on a One-on-One basis via VC. The latest Earnings Presentation and Corporate Presentation to be discussed have already been placed on the website of the Company: www.epigral.com. No unpublished price sensitive information will be shared/discussed in the meeting with the Investors.
The above information is a part of company’s filings submitted to BSE.
